文献速递临床试验与 GCP真实世界研究与卫生经济医学教育与科研方法

印度城市低收入学校非专业顾问提供的简短问题解决干预对青少年的12个月效果与成本

Effectiveness and costs associated with a lay counselor-delivered, brief problem-solving mental health intervention for adolescents in urban, low-income schools in India: 12-month outcomes of a randomized controlled trial.
PubMed 文献 · PLoS Med · 2021-09-28

该研究在印度新德里6所政府学校对250名存在心理社会问题的青少年开展随机对照试验,比较非专业顾问提供的简短问题解决干预与仅自助手册的效果。12个月随访显示干预对心理社会问题和心理健康症状有持续效果,且扩大规模成本可负担。

要点

  • 非专业顾问提供的简短问题解决干预在12个月时对青少年心理社会问题有持续改善效果。
  • 扩大干预规模每名学生成本约4美元,每例约23美元,占学校预算0.4%。
  • 研究为事后延长随访,样本量未针对12个月随访计算,结果需谨慎解读。

核心结论

  • 非专业顾问提供的简短跨诊断问题解决干预对青少年心理社会问题和心理健康症状有持续效果。
  • 该资源高效干预扩大规模是低收入地区改善青少年心理保健可负担的政策目标。

研究设计与样本

  • 研究为两臂随机对照试验的事后12个月随访扩展,纳入新德里6所政府学校的250名青少年(平均年龄15.61岁,SD=1.68,174名男性占69.6%)。
  • 干预组接受非专业顾问提供的4–5次问题解决干预(3周内)加自助手册,对照组仅接受自助手册。
  • 主要结局为青少年报告的心理社会问题(YTP)和心理健康症状(SDQ总困难量表)。

主要发现

  • 12个月时YTP调整均差为-0.75(95%CI -1.47至-0.03,p=0.04),SDQ总困难调整均差为-1.73(95%CI -3.47至0.02,p=0.05)。
  • 12个月期间YTP调整均差为-0.98(95%CI -1.51至-0.45,p<0.001),SDQ总困难调整均差为-1.23(95%CI -2.37至-0.09,p=0.03)。
  • 12个月期间干预对内化症状、功能损害、感知压力和幸福感也有改善效果。
  • 试验期间每名学生干预成本为3美元(每例158美元),扩大规模模拟场景下每名学生4美元(每例23美元)。

关键数值与推荐

  • YTP在12个月时调整均差-0.75(95%CI -1.47至-0.03,p=0.04)。
  • SDQ总困难在12个月时调整均差-1.73(95%CI -3.47至0.02,p=0.05)。
  • 12个月期间YTP调整均差-0.98(95%CI -1.51至-0.45,p<0.001)。
  • 12个月期间SDQ总困难调整均差-1.23(95%CI -2.37至-0.09,p=0.03)。
  • 扩大规模成本占新德里每名学生学校预算的0.4%。

临床怎么用

  • 在低收入学校环境中,可由非专业顾问提供简短问题解决干预以改善青少年心理健康。
  • 该干预扩大规模成本较低,可作为改善青少年心理保健可及性的可行策略。

局限性

  • 研究为事后延长随访,样本量计算未针对12个月随访进行。
  • 未进行基于主要结局的成本效果分析。
  • 长期随访中失访率较高,结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psychosocial interventions for adolescent mental health problems are effective, but evidence on their longer-term outcomes is scarce, especially in low-resource settings. We report on the 12-month sustained effectiveness and costs of scaling up a lay counselor-delivered, transdiagnostic problem-solving intervention for common adolescent mental health problems in low-income schools in New Delhi, India. METHODS AND FINDINGS: Participants in the original trial were 250 school-going adolescents (mean [M] age = 15.61 years, standard deviation [SD] = 1.68), including 174 (69.6%) who identified as male. Participants were recruited from 6 government schools over a period of 4 months (August 20 to December 14, 2018) and were selected on the basis of elevated mental health symptoms and distress/functional impairment. A 2-arm, randomized controlled trial design was used to examine the effectiveness of a lay counselor-delivered, problem-solving intervention (4 to 5 sessions over 3 weeks) with supporting printed booklets (intervention arm) in comparison with problem solving delivered via printed booklets alone (control arm), at the original endpoints of 6 and 12 weeks. The protocol was modified, as per the recommendation of the Trial Steering Committee, to include a post hoc extension of the follow-up period to 12 months. Primary outcomes were adolescent-reported psychosocial problems (Youth Top Problems [YTP]) and mental health symptoms (Strengths and Difficulties Questionnaire [SDQ] Total Difficulties scale). Other self-reported outcomes included SDQ subscales, perceived stress, well-being, and remission. The sustained effects of the intervention were estimated at the 12-month endpoint and over 12 months (the latter assumed a constant effect across 3 follow-up points) using a linear mixed model for repeated measures and involving complete case analysis. Sensitivity analyses examined the effect of missing data using multiple imputations. Costs were estimated for delivering the intervention during the trial and from modeling a scale-up scenario, using a retrospective ingredients approach. Out of the 250 original trial participants, 176 (70.4%) adolescents participated in the 12-month follow-up assessment. One adverse event was identified during follow-up and deemed unrelated to the intervention. Evidence was found for intervention effects on both SDQ Total Difficulties and YTP at 12 months (YTP: adjusted mean difference [AMD] = -0.75, 95% confidence interval [CI] = -1.47, -0.03, p = 0.04; SDQ Total Difficulties: AMD = -1.73, 95% CI = -3.47, 0.02, p = 0.05), with stronger effects over 12 months (YTP: AMD = -0.98, 95% CI = -1.51, -0.45, p < 0.001; SDQ Total Difficulties: AMD = -1.23, 95% CI = -2.37, -0.09; p = 0.03). There was also evidence for intervention effects on internalizing symptoms, impairment, perceived stress, and well-being over 12 months. The intervention effect was stable for most outcomes on sensitivity analyses adjusting for missing data; however, for SDQ Total Difficulties and impairment, the effect was slightly attenuated. The per-student cost of delivering the intervention during the trial was $3 United States dollars (USD; or $158 USD per case) and for scaling up the intervention in the modeled scenario was $4 USD (or $23 USD per case). The scaling up cost accounted for 0.4% of the per-student school budget in New Delhi. The main limitations of the study's methodology were the lack of sample size calculations powered for 12-month follow-up and the absence of cost-effectiveness analyses using the primary outcomes. CONCLUSIONS: In this study, we observed that a lay counselor-delivered, brief transdiagnostic problem-solving intervention had sustained effects on psychosocial problems and mental health symptoms over the 12-month follow-up period. Scaling up this resource-efficient intervention is an affordable policy goal for improving adolescents' access to mental health care in low-resource settings. The findings need to be interpreted with caution, as this study was a post hoc extension, and thus, the sample size calculations did not take into account the relatively high attrition rate observed during the long-term follow-up. TRIAL REGISTRATION: ClinicalTrials.gov NCT03630471.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Malik K, Michelson D, Doyle AM, et al. Effectiveness and costs associated with a lay counselor-delivered, brief problem-solving mental health intervention for adolescents in urban, low-income schools in India: 12-month outcomes of a randomized controlled trial. PLoS Med. 2021. PMID: 34582460. doi:10.1371/journal.pmed.1003778

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。